资讯
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
The PLATFORM-CM trial is evaluating oteseconazole and other investigational products against the standard of care for treating cryptococcal meningitis DURHAM, NC, USA I June 4, 2025 I Mycovia ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果